KMDA

Peers: BHC KNSA PRGO ALKS AMRX INDV TEVA VTRS LNTH TLX

| Held by: DISV DFIS DFIC AIMS DFAX IBBQ BIB

Index	-
Market Cap	472.97M
Enterprise Value	414.64M
Income	22.25M
Sales	191.85M
Book/sh	4.67
Cash/sh	1.22
Dividend Est.	-
Dividend TTM	0.42 (5.12%)
Dividend Ex-Date	Aug 27, 2026
Dividend Gr. 3/5Y	- -
Payout	64.45%
Employees	462
IPO	May 31, 2013

P/E	21.48
Forward P/E	13.74
PEG	0.60
P/S	2.47
P/B	1.75
P/C	6.74
P/FCF	17.12
EV/EBITDA	9.62
EV/Sales	2.16
Quick Ratio	2.29
Current Ratio	4.06
Debt/Eq	0.04
LT Debt/Eq	0.04
Option/Short	Yes / Yes

EPS (ttm)	0.38
EPS next Y	0.60
EPS next Q	0.13
EPS this Y	33.69%
EPS next Y	22.39%
EPS next 5Y	23.09%
EPS past 3/5Y	- -2.03%
Sales past 3/5Y	11.74% 6.25%
EPS Y/Y TTM	16.67%
Sales Y/Y TTM	13.17%
EPS Q/Q	25.10%
Sales Q/Q	22.72%
Earnings	Aug 12 BMO
EPS/Sales Surpr.	53.24% 8.03%

Insider Own	45.48%
Insider Trans	0.00%
Inst Own	16.45%
Inst Trans	-3.45%
ROA	5.92%
ROE	8.40%
ROIC	7.97%
Gross Margin	40.82%
Oper. Margin	14.50%
Profit Margin	11.60%
SMA20	5.88%
SMA50	10.70%
SMA200	5.11%
Trades

Shs Outstand	57.69M
Shs Float	31.46M
Short Float	0.48%
Short Ratio	1.93
Short Interest	0.15M
52W High	9.35 -12.32%
52W Low	6.50 26.13%
Volatility	2.83% 3.00%
ATR (14)	0.22
RSI (14)	62.03
Beta	0.91
Rel Volume	0.26
Avg Volume	77.49K
Volume	1,026

Perf Week	-2.75%
Perf Month	14.82%
Perf Quarter	6.47%
Perf Half Y	-9.61%
Perf YTD	16.13%
Perf Year	18.48%
Perf 3Y	42.58%
Perf 5Y	52.39%
Perf 10Y	70.09%
Recom	1.00
Target Price	13.50
Prev Close	8.29
Price	8.20
Change %	-1.10%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-21-25	Initiated	The Benchmark Company	Buy	$15
Jul-03-24	Initiated	Stifel	Buy	$18
Feb-02-18	Initiated	Chardan Capital Markets	Buy	$7

Aug-17-26 07:00AM	Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026 (GlobeNewswire)
Aug-12-26 07:03PM	Kamada Ltd (KMDA) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic Expansion ... (GuruFocus.com) +5.52%
01:20PM	Kamada Ltd. Q2 2026 Earnings Call Summary (Moby)
07:17AM	Kamada: Q2 Earnings Snapshot (Associated Press)
07:05AM	Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance (GlobeNewswire)
07:00AM	Loading…
07:00AM	Kamada Announces Planned Transition of Chief Financial Officer (GlobeNewswire)
Aug-11-26 09:21AM	Earnings To Watch: Kamada Ltd (KMDA) Q2 2026 -- GF Value Sees 32% Upside (GuruFocus.com)
Aug-05-26 07:00AM	Kamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026 (GlobeNewswire)
Jul-20-26 07:00AM	Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies (GlobeNewswire)
Jul-13-26 07:00AM	Kamada Highlights CYTOGAM Study Results Presented at the 2026 ISHLT Annual Meeting (GlobeNewswire)
Jun-01-26 07:00AM	Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory (GlobeNewswire)
May-13-26 07:01PM	Kamada Ltd (KMDA) Q1 2026 Earnings Call Highlights: Strategic Growth Amid Shipment Delays (GuruFocus.com) -6.76%
12:48PM	Kamada Ltd. Q1 2026 Earnings Call Summary (Moby)
07:13AM	Kamada: Q1 Earnings Snapshot (Associated Press)
07:00AM	Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year (GlobeNewswire)
07:00AM	Loading…
May-06-26 07:00AM	Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026 (GlobeNewswire)
Mar-31-26 07:00AM	Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders (GlobeNewswire)
Mar-26-26 07:00AM	Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas (GlobeNewswire)
Mar-11-26 03:02PM	Kamada Ltd (KMDA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook (GuruFocus.com)
07:23AM	Kamada: Q4 Earnings Snapshot (Associated Press Finance)
07:02AM	Kamada Reports Record Top- and Bottom-line 2025 Financial Results and Affirms 2026 Guidance Representing Continued Double-Digit Organic Profitable Growth (GlobeNewswire)
07:00AM	Kamada Declares Cash Dividend of $0.25 Per Share, to be Paid in Accordance with an Adopted Annual Cash Dividend Policy (GlobeNewswire)
Mar-10-26 09:23AM	Earnings To Watch: Kamada Ltd (KMDA) Reports Q4 2025 Result (GuruFocus.com)
Mar-06-26 09:15AM	Ahead of Kamada (KMDA) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Mar-05-26 11:40AM	KMDA vs. ARGX: Which Stock Is the Better Value Option? (Zacks)
Mar-04-26 07:00AM	Kamada to Announce Fiscal Year and Fourth Quarter 2025 Financial Results on March 11, 2026 (GlobeNewswire)
Feb-17-26 11:40AM	KMDA or TECH: Which Is the Better Value Stock Right Now? (Zacks) +6.82%
09:40AM	Are Investors Undervaluing Kamada (KMDA) Right Now? (Zacks)
Jan-27-26 08:21AM	Kamada (KMDA) Soars 8.1%: Is Further Upside Left in the Stock? (Zacks)
Jan-09-26 05:07PM	Hubspot Stock Set to Rise, Says Analyst. Plus, McGraw Hill, UHS, and More Stocks. (Barrons.com)
07:00AM	Loading…
Jan-07-26 07:00AM	Kamada Provides 2026 Annual Guidance of $200 - $205 Million in Revenues and $50 - $53 Million of Adjusted EBITDA, Representing Double-Digit Growth and Affirms 2025 Financial Guidance (GlobeNewswire) +5.79%
Dec-18-25 07:00AM	Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender (GlobeNewswire)
Dec-08-25 07:00AM	Kamada Announces Discontinuation of its Phase 3 Inhaled AAT Clinical Trial; Reiterates 2025 Full-Year Guidance and Projects Double-Digit Growth in Revenues and Profitability in 2026 (GlobeNewswire)
Nov-11-25 12:45PM	Kamada (KMDA) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
Nov-10-25 04:00PM	Kamada Ltd (KMDA) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements (GuruFocus.com) +5.41%
09:30AM	Kamada (KMDA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:15AM	Kamada (KMDA) Misses Q3 Earnings Estimates (Zacks)
07:00AM	Kamada Reports Strong Third Quarter and Nine Month 2025 Financial Results with over 30% Year-over-Year Profitability Growth (GlobeNewswire)
Nov-07-25 07:21AM	Earnings To Watch: Kamada Ltd (KMDA) Reports Q3 2025 Result (GuruFocus.com)
Nov-06-25 09:15AM	Countdown to Kamada (KMDA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
08:25AM	Regenxbio (RGNX) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
Nov-05-25 10:55AM	Ocugen (OCGN) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
09:40AM	Should Value Investors Buy Kamada (KMDA) Stock? (Zacks)
Nov-04-25 07:00AM	Kamada Announces First Patient Enrolled into an Investigator-Initiated Clinical Trial of CYTOGAM to Prevent Cytomegalovirus in Kidney Transplantation (GlobeNewswire)
Nov-03-25 07:00AM	Kamada to Announce Third Quarter and Nine Months Ended September 30, 2025 Financial Results on November 10, 2025 (GlobeNewswire)
Oct-31-25 12:07PM	KMDA vs. NVZMY: Which Stock Is the Better Value Option? (Zacks)
Oct-30-25 09:55AM	Wall Street Analysts Believe Kamada (KMDA) Could Rally 113.15%: Here's is How to Trade (Zacks)
Oct-29-25 07:00AM	Kamada to Present at the Stifel 2025 Healthcare Conference (GlobeNewswire)
Oct-22-25 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Kamada (KMDA) (Zacks)
Oct-20-25 09:40AM	Are Investors Undervaluing Kamada (KMDA) Right Now? (Zacks)
Oct-15-25 11:40AM	KMDA or ILMN: Which Is the Better Value Stock Right Now? (Zacks)
Oct-14-25 09:55AM	Does Kamada (KMDA) Have the Potential to Rally 114.39% as Wall Street Analysts Expect? (Zacks)
Oct-06-25 12:45PM	Is Kamada (KMDA) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
Oct-03-25 09:40AM	Should Value Investors Buy Kamada (KMDA) Stock? (Zacks)
Sep-29-25 11:40AM	KMDA vs. ILMN: Which Stock Is the Better Value Option? (Zacks)
Sep-17-25 09:40AM	Are Investors Undervaluing Kamada (KMDA) Right Now? (Zacks)
Sep-03-25 12:45PM	Kamada (KMDA) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
09:55AM	Wall Street Analysts See an 110.11% Upside in Kamada (KMDA): Can the Stock Really Move This High? (Zacks)
09:15AM	Halozyme Therapeutics, Inc. (HALO) Hit a 52 Week High, Can the Run Continue? (Zacks)
Sep-02-25 07:00AM	Kamada to Participate in Upcoming September Investor Conferences (GlobeNewswire)
Sep-01-25 11:40AM	KMDA or ARGX: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Should Value Investors Buy Kamada (KMDA) Stock? (Zacks)
Aug-18-25 12:45PM	3 Reasons Growth Investors Will Love Kamada (KMDA) (Zacks)
Aug-14-25 12:00PM	What Makes Kamada (KMDA) a New Buy Stock (Zacks)
11:40AM	KMDA vs. ILMN: Which Stock Is the Better Value Option? (Zacks)
09:40AM	Are Investors Undervaluing Kamada (KMDA) Right Now? (Zacks)
03:08AM	Kamada Ltd (KMDA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Increased ... (GuruFocus.com)
Aug-13-25 09:30AM	Kamada (KMDA) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
08:20AM	Kamada (KMDA) Q2 Earnings Top Estimates (Zacks)
07:00AM	Kamada Reports Strong Second Quarter and First Half 2025 Financial Results with 11% Year-Over-Year 6-Month Top Line Growth and a 35% Increase in Profitability; Raises Full-Year Profitability Guidance (GlobeNewswire)
Aug-12-25 03:00PM	Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Aug-11-25 07:00AM	Kamada Announces FDA Approval of its Plasma Collection Center in Houston, Texas (GlobeNewswire)
Aug-08-25 09:15AM	Exploring Analyst Estimates for Kamada (KMDA) Q2 Earnings, Beyond Revenue and EPS (Zacks)
Aug-07-25 06:40PM	Verastem (VSTM) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Aug-06-25 07:00AM	Kamada to Announce Second Quarter and First Half Ended June 30, 2025 Financial Results on August 13, 2025 (GlobeNewswire)
Jul-04-25 11:40AM	KMDA or ACAD: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Is Kamada (KMDA) Stock Undervalued Right Now? (Zacks)
Jun-25-25 11:14AM	Strength Seen in Kamada (KMDA): Can Its 9.5% Jump Turn into More Strength? (Zacks)
Jun-18-25 11:40AM	KMDA vs. ACAD: Which Stock Is the Better Value Option? (Zacks)
09:40AM	Should Value Investors Buy Kamada (KMDA) Stock? (Zacks)
Jun-17-25 07:00AM	Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East (GlobeNewswire)
Jun-10-25 10:21AM	Implied Volatility Surging for Kamada Stock Options (Zacks)
Jun-02-25 09:55AM	Wall Street Analysts Think Kamada (KMDA) Could Surge 106.86%: Read This Before Placing a Bet (Zacks)
09:40AM	Are Investors Undervaluing Kamada (KMDA) Right Now? (Zacks)
May-28-25 11:40AM	KMDA vs. CSLLY: Which Stock Should Value Investors Buy Now? (Zacks)
May-16-25 09:55AM	Wall Street Analysts Believe Kamada (KMDA) Could Rally 106.56%: Here's is How to Trade (Zacks)
09:40AM	Is Kamada (KMDA) Stock Undervalued Right Now? (Zacks)
May-14-25 09:30AM	Compared to Estimates, Kamada (KMDA) Q1 Earnings: A Look at Key Metrics (Zacks)
08:10AM	Kamada (KMDA) Q1 Earnings Match Estimates (Zacks)
07:00AM	Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year Top Line Growth of 17% and a 54% Increase in Profitability (GlobeNewswire)
May-13-25 08:50AM	XOMA Royalty (XOMA) Tops Q1 Earnings and Revenue Estimates (Zacks)
May-09-25 09:15AM	Kamada (KMDA) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
May-08-25 05:55PM	Puma Biotech (PBYI) Q1 Earnings and Revenues Top Estimates (Zacks)
May-07-25 06:35PM	Nuvation Bio Inc. (NUVB) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025 (GlobeNewswire)
May-06-25 07:10PM	Keros Therapeutics, Inc. (KROS) Q1 Earnings and Revenues Beat Estimates (Zacks)
May-05-25 07:00AM	Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for CYTOGAM (GlobeNewswire)
Mar-24-25 07:00AM	Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders (GlobeNewswire) +5.65%
Mar-19-25 07:00AM	Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas (GlobeNewswire)
Mar-18-25 09:00AM	Sidoti Events, LLC's Virtual March Small-Cap Conference (ACCESSWIRE)

Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment refers to specialty plasma therapies and normal source plasma (NSP). The Distribution segment focuses on the commercialization of in-licensed third-party biopharmaceutical products. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.

Chief Executive OfficerMr. Amir London

Chief Financial OfficerMr. Chaime Orlev

Chief Operating OfficerMr. Eran Nir

Vice President of US Commercial OperationsMr. Jon R. Knight

Vice President of Business Development & Strategic ProgramsMr. Boris Gorelik

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Brenner Yael	VP Quality	Aug 26 '26	Option Exercise	6.25	30,000	187,500	16,266	Aug 31 07:00 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Kamada Ltd

Upgrade your Finviz experience